enterovirus 71; enterovirus A71 (EV71, EV-A71)
Jump to navigation
Jump to search
Epidemiology
- Asia-Pacific region
- outbreak of enterovirus A71 in Colorado (2018), 34 children with neurologic disease
- cases of meningitis (12), encephalitis (9), flaccid myelitis (3), ataxia (7), myoclonus (6)
Pathology
- common cause of
- morbidity & mortality from EV71 infection is low
Laboratory
Management
- Enterovirus 71 vaccine effective[1]
More general terms
Additional terms
References
- ↑ Jump up to: 1.0 1.1 Zhu FC et al Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. May 29, 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23726161 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61049-1/abstract
- ↑ Messacar K, Burakoff A, Nix WA, et al. Notes from the Field: Enterovirus A71 Neurologic Disease in Children
Colorado, 2018. MMWR Morb Mortal Wkly Rep 2018;67:1017-1081 https://www.cdc.gov/mmwr/volumes/67/wr/mm6736a5.htm